Literature DB >> 11899099

Melatonin-immune system relationships.

Juan M Guerrero1, Russel J Reiter.   

Abstract

In this paper we review the historical milestones that first highlighted the existence of a relationship between melatonin and the immune system and we summarize data from experiments which correlate the rhythmic production of melatonin with the rhythmic activity of the immune system. The effects of pinealectomy and in vivo administration of melatonin on a variety of immune parameters, including specific and non-specific immunity are considered and we also present contradictory data concerning the effect of melatonin in cultured immunocompetent cells and a possible scheme of how melatonin regulates the production of a number of cytokines. Finally, the mechanism of action of melatonin in the immune system is discussed. Many data suggest the existence of both nuclear and membrane receptors for melatonin in the immune system. Both of these appear to be clearly identified but their specific physiological role is still under discussion. In summary, although there is overwhelming information demonstrating the immunoenhancing properties of melatonin, many questions related to the cytokines involved and the mechanisms of action of the indoleamine require answers.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11899099     DOI: 10.2174/1568026023394335

Source DB:  PubMed          Journal:  Curr Top Med Chem        ISSN: 1568-0266            Impact factor:   3.295


  90 in total

1.  Differential effects of melatonin as a broad range UV-damage preventive dermato-endocrine regulator.

Authors:  Konrad Kleszczyński; Lena H Hardkop; Tobias W Fischer
Journal:  Dermatoendocrinol       Date:  2011-01

Review 2.  The role of melatonin in immuno-enhancement: potential application in cancer.

Authors:  Sandra C Miller; S R Pandi-Perumal; Perumal S R Pandi; Ana I Esquifino; Daniel P Cardinali; Georges J M Maestroni
Journal:  Int J Exp Pathol       Date:  2006-04       Impact factor: 1.925

Review 3.  Melatonin antioxidative defense: therapeutical implications for aging and neurodegenerative processes.

Authors:  Seithikurippu R Pandi-Perumal; Ahmed S BaHammam; Gregory M Brown; D Warren Spence; Vijay K Bharti; Charanjit Kaur; Rüdiger Hardeland; Daniel P Cardinali
Journal:  Neurotox Res       Date:  2012-06-28       Impact factor: 3.911

Review 4.  The circadian control of skin and cutaneous photodamage.

Authors:  Joshua A Desotelle; Melissa J Wilking; Nihal Ahmad
Journal:  Photochem Photobiol       Date:  2012-02-21       Impact factor: 3.421

Review 5.  A review of the multiple actions of melatonin on the immune system.

Authors:  Antonio Carrillo-Vico; Juan M Guerrero; Patricia J Lardone; Russel J Reiter
Journal:  Endocrine       Date:  2005-07       Impact factor: 3.633

6.  Nocturnal melatonin concentration is correlated with illness severity in patients with septic disease.

Authors:  Boris Perras; Volkhard Kurowski; Christoph Dodt
Journal:  Intensive Care Med       Date:  2006-02-14       Impact factor: 17.440

Review 7.  Seasonal changes in vertebrate immune activity: mediation by physiological trade-offs.

Authors:  Lynn B Martin; Zachary M Weil; Randy J Nelson
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2008-01-27       Impact factor: 6.237

Review 8.  New therapeutic perspectives in irritable bowel syndrome: Targeting low-grade inflammation, immuno-neuroendocrine axis, motility, secretion and beyond.

Authors:  Emanuele Sinagra; Gaetano Cristian Morreale; Ghazaleh Mohammadian; Giorgio Fusco; Valentina Guarnotta; Giovanni Tomasello; Francesco Cappello; Francesca Rossi; Georgios Amvrosiadis; Dario Raimondo
Journal:  World J Gastroenterol       Date:  2017-09-28       Impact factor: 5.742

9.  Efficacy of N-Acetylserotonin and Melatonin in the EAE Model of Multiple Sclerosis.

Authors:  Jie Wen; Prasanth S Ariyannur; Rachel Ribeiro; Mikiei Tanaka; John R Moffett; Batool F Kirmani; Aryan M A Namboodiri; Yumin Zhang
Journal:  J Neuroimmune Pharmacol       Date:  2016-08-25       Impact factor: 4.147

10.  Melatonin regulation as a possible mechanism for probiotic (VSL#3) in irritable bowel syndrome: a randomized double-blinded placebo study.

Authors:  Reuben K Wong; Cao Yang; Guang-Hui Song; Jennie Wong; Khek-Yu Ho
Journal:  Dig Dis Sci       Date:  2014-08-05       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.